Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy
Amy R Brooks-Kayal, Kevin G Bath, Anne T Berg, Aristea S Galanopoulou, Gregory L Holmes, Frances E Jensen, Andres M Kanner, Terence J O'Brien, Vicky H Whittemore, Melodie R Winawer, Manisha Patel, Helen E Scharfman
Epilepsia | WILEY | Published : 2013
Awarded by Office of the Director
Funding sources: R01NS38595 and grants from CURE, AES, the Epilepsy Foundation (EF) and the Colorado Center for Drug Discovery (ARB-K); NARSAD and EF (KGB); R37NS31146 and a grant from the Pediatric Epilepsy Foundation (ATB); R21NS078333 and R01NS020253 and grants from Autism Speaks, CURE, Heffer and Siegel Families Foundations (ASG); R01NS061991 and CURE (MRW); RO1NS039587, CURE, and Office of the Director grant R21NS072099 (MP); R01NS37562, R21MH090606, the Alzheimer's Association, and NYS Office of Mental Health (HES).